Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
MasterCard
MA
US Stock MarketDetailed Quotes
WINT Windtree Therapeutics
- 0.9000
- -0.1200-11.76%
Close May 6 16:00 ET
3.20MMarket Cap-0.04P/E (TTM)
0.9900High0.8280Low1.54MVolume0.9500Open1.0200Pre Close1.49MTurnover43.45%Turnover RatioLossP/E (Static)3.56MShares737.435052wk High0.32P/B3.20MFloat Cap0.828052wk Low--Dividend TTM3.56MShs Float167075916.4620Historical High--Div YieldTTM15.88%Amplitude0.8280Historical Low0.9640Avg Price1Lot Size
About Windtree Therapeutics Company
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. It's portfolio of product candidates includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure and preclinical precision aPKCi inhibitors that are being developed for potential in rare and broad oncology applications. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.
Company Profile
SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Jed A. Latkin
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300
Websitehttp://www.windtreetx.com
Company Executives
- Name
- Position
- Salary
- Jed A. Latkin
- Director, President and Chief Executive Officer
- --
- Jamie McAndrew
- Senior Vice President, Principal Accounting Officer and Chief Financial Officer
- --
- Eric Curtis
- Senior Vice President and Chief Operating Officer
- 451.73K
- Dr. Steven G. Simonson, M.D.
- Senior Vice President and Chief Medical Officer
- 491.73K
- Dr. Mark Strobeck, PhD
- Chairman of the Board
- 32.34K
- Leanne M. Kelly
- Independent Director
- --
- Saundra Pelletier
- Independent Director
- --
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now